Phosphodiesterase-5 Inhibitor Therapy for Left Ventricular Assist Device Patients: More Data, More Questions

J Am Heart Assoc. 2020 Jul 21;9(14):e017585. doi: 10.1161/JAHA.120.017585. Epub 2020 Jul 10.
No abstract available

Keywords: Editorials; bleeding; left ventricular assist device; phosphodiesterase inhibitor; stroke; thrombosis.

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Cyclic Nucleotide Phosphodiesterases, Type 5
  • Heart Failure* / therapy
  • Heart-Assist Devices*
  • Humans
  • Phosphodiesterase 5 Inhibitors / adverse effects
  • Thrombosis*

Substances

  • Phosphodiesterase 5 Inhibitors
  • Cyclic Nucleotide Phosphodiesterases, Type 5